New MRI scan could reveal hidden brain tumors
NCT ID NCT07272616
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new MRI sequence that aims to make brain tumors (metastases) more visible after a standard contrast injection. Researchers will compare the new method to the usual MRI in 100 adults with known or suspected brain tumors. The goal is to see if the new scan finds more or smaller tumors without increasing contrast dose or scan time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Gadolinium-based contrast agent
- What this could lead to
- If successful, this new MRI method could help doctors find more brain tumors, especially small ones, leading to earlier and more accurate diagnosis.
- What could go wrong
- This is a small, early-phase study with only 100 participants. The new method may not detect more tumors than standard MRI, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN METASTASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Karolinska University Hospital
RECRUITINGStockholm, Solna, 1171 76, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Sound waves could make brain tumor diagnosis safer and smarter
- Childhood brain tumor survivors face hidden hormone risks years later
- Can a 3D camera make brain radiation safer and more precise?
- Pinpoint radiation may spare the brain in lung cancer that spreads
- Spinal fluid DNA test could personalize brain cancer therapy
- Focused radiation doses put to the test for large brain tumors